Nicholas Company Inc. trimmed its position in Steris PLC (NYSE:STE) by 3.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 63,190 shares of the medical equipment provider’s stock after selling 2,300 shares during the period. Nicholas Company Inc. owned approximately 0.07% of Steris worth $6,751,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Oregon Public Employees Retirement Fund raised its stake in Steris by 10,585.0% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 3,572,743 shares of the medical equipment provider’s stock valued at $33,000 after purchasing an additional 3,539,306 shares during the period. Enlightenment Research LLC acquired a new stake in Steris during the 4th quarter valued at $53,000. Rehmann Capital Advisory Group raised its stake in Steris by 15.6% during the 3rd quarter. Rehmann Capital Advisory Group now owns 712 shares of the medical equipment provider’s stock valued at $81,000 after purchasing an additional 96 shares during the period. Bartlett & Co. LLC raised its stake in Steris by 76.4% during the 4th quarter. Bartlett & Co. LLC now owns 1,235 shares of the medical equipment provider’s stock valued at $132,000 after purchasing an additional 535 shares during the period. Finally, Cornerstone Advisors Inc. raised its stake in Steris by 303.3% during the 3rd quarter. Cornerstone Advisors Inc. now owns 1,476 shares of the medical equipment provider’s stock valued at $169,000 after purchasing an additional 1,110 shares during the period. Hedge funds and other institutional investors own 87.10% of the company’s stock.
NYSE STE opened at $123.38 on Friday. Steris PLC has a 1-year low of $89.67 and a 1-year high of $124.26. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.99 and a current ratio of 2.56. The firm has a market capitalization of $10.44 billion, a PE ratio of 29.73 and a beta of 1.07.
Steris (NYSE:STE) last posted its quarterly earnings results on Monday, February 11th. The medical equipment provider reported $1.26 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $1.26. Steris had a net margin of 9.85% and a return on equity of 12.50%. The business had revenue of $696.24 million for the quarter, compared to the consensus estimate of $687.90 million. On average, sell-side analysts predict that Steris PLC will post 4.78 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Thursday, March 21st. Stockholders of record on Wednesday, February 27th will be paid a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.10%. The ex-dividend date of this dividend is Tuesday, February 26th. Steris’s dividend payout ratio (DPR) is presently 32.77%.
STE has been the topic of several recent analyst reports. Sidoti boosted their target price on shares of Steris from $155.00 to $157.00 and gave the company a “buy” rating in a research note on Thursday, December 6th. JMP Securities reissued a “buy” rating and set a $135.00 target price on shares of Steris in a research note on Thursday, February 14th. Finally, Stephens reaffirmed a “buy” rating and issued a $135.00 price target on shares of Steris in a research note on Thursday, February 14th. Five equities research analysts have rated the stock with a buy rating, The stock has a consensus rating of “Buy” and an average price target of $138.20.
In other Steris news, VP John Adam Zangerle sold 3,000 shares of the stock in a transaction on Friday, January 25th. The shares were sold at an average price of $115.00, for a total transaction of $345,000.00. Following the transaction, the vice president now directly owns 33,796 shares of the company’s stock, valued at $3,886,540. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Michael B. Wood sold 3,609 shares of the stock in a transaction on Friday, March 1st. The stock was sold at an average price of $121.79, for a total transaction of $439,540.11. The disclosure for this sale can be found here. Insiders sold 10,396 shares of company stock worth $1,226,593 over the last ninety days. 2.38% of the stock is currently owned by company insiders.
Steris Company Profile
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.
See Also: Analyst Ratings Trading
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.